99 Cents Only Stores  

(Public, NYSE:NDN)   Watch this stock  
Find more results for NDN
0.0000
Real-time:  
NYSE real-time data - Disclaimer
Currency in
Range     -
52 week 14.57 - 22.03
Open     -
Vol / Avg. 0.00/744,732.00
Mkt cap 1.55B
P/E 0.00
Div/yield     -
EPS 1.09
Shares 70.60M
Beta 0.47
Inst. own 66%
Jul 1, 2013
Q4 2013 99 CENTS Only Earnings Release Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '12) 2012
Net profit margin 2.89% 2.90%
Operating margin 7.85% 6.29%
EBITD margin - 8.51%
Return on average assets 2.85% 3.43%
Return on average equity 8.04% 6.78%
Employees 12,800 -
Carbon Disclosure Rating - -

Address

4000 Union Pacific Ave.
CITY OF COMMERCE, CA 90023
United States - Map
+1-323-9808145 (Phone)
+1-323-9808160 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

99 Cents Only Stores is a United States-based company, which operates as retail stores that sells general merchandise. The Company is a deep-discount retailer. It sells name-brand and private-label food and beverages, health and beauty aids, household goods, hardware, toys, and more. It offers consumable products including food and beverages such as produce, deli, and other basic grocery items. It also offers Club 99 where online shopping is provided.

Officers and directors

Eric Schiffer Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Robert Kautz Chief Financial Officer, Executive Vice President
Age: 53
Bio & Compensation  - Reuters
Jeff Gold President, Chief Operating Officer, Director
Age: 43
Bio & Compensation  - Reuters
Howard Gold Executive Vice President - Special Projects, Director
Age: 51
Bio & Compensation  - Reuters
Norman Axelrod Director
Bio & Compensation  - Reuters
Shane Feeney Director
Bio & Compensation  - Reuters
Dennis Gies Director
Bio & Compensation  - Reuters
Marvin L. Holen Director
Bio & Compensation  - Reuters
David Kaplan Director
Bio & Compensation  - Reuters